These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8433507)

  • 1. [Prostacyclin stability in thrombotic thrombocytopenic purpura. Japan Working Group on TTP].
    Koyama T; Kakishita E
    Nihon Rinsho; 1993 Jan; 51(1):142-5. PubMed ID: 8433507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the pathogenesis and management of thrombotic thrombocytopenic purpura.
    Kakishita E; Nakajima T; Suehiro A; Koyama T; Ueda M; Tsujioka H; Yoshimoto H
    Pol J Pharmacol; 1996; 48(2):179-84. PubMed ID: 9112648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura.
    Bobbio-Pallavicini E; Porta C; Tacconi F; Gugliotta L; Centurioni R; Vianelli N; Billio A; Ascari E
    Haematologica; 1994; 79(5):429-37. PubMed ID: 7843629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
    Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL
    J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombotic thrombocytopenic purpura (TTP) with a low level of apolipoprotein A-I (Apo A-I) which responded to combination of vincristine and beraprost].
    Kurosawa S; Nagata M; Saito T; Arai T; Momose T; Morio K; Mitsuhashi H
    Rinsho Ketsueki; 1994 Jul; 35(7):704-9. PubMed ID: 8065025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
    Lian EC
    Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
    Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P
    Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura.
    Wu KK; Hall ER; Rossi EC; Papp AC
    J Clin Invest; 1985 Jan; 75(1):168-74. PubMed ID: 3880771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura.
    Chen YC; McLeod B; Hall ER; Wu KK
    Lancet; 1981 Aug; 2(8241):267-9. PubMed ID: 6114320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of prostacyclin in human and rabbit whole blood and plasma.
    Lucas FV; Skrinska VA; Chisolm GM; Hesse BL
    Thromb Res; 1986 Aug; 43(4):379-87. PubMed ID: 3532417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of increased platelet aggregation in TTP.
    Lian EC
    Semin Thromb Hemost; 1980; 6(4):401-15. PubMed ID: 7013071
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
    Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombotic thrombocytopenic purpura--recent development of TTP study].
    Ito K
    Nihon Rinsho; 1993 Jan; 51(1):114-6. PubMed ID: 8381882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura.
    Jilma-Stohlawetz P; Gorczyca ME; Jilma B; Siller-Matula J; Gilbert JC; Knöbl P
    Thromb Haemost; 2011 Mar; 105(3):545-52. PubMed ID: 21174003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumption.
    Neame PB; Hirsh J; Browman G; Denburg J; D'Souza TJ; Gallus A; Brain MC
    Can Med Assoc J; 1976 Jun; 114(12):1108-12. PubMed ID: 1084215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura.
    Lian EC
    Annu Rev Med; 1988; 39():203-12. PubMed ID: 3285772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregating activity of plasma in patients with thrombotic thrombocytopenic purpura evaluated by a particle counting method using light scattering.
    Suehiro A; Yoshimoto H; Higasa S; Kakishita E
    Int J Hematol; 1999 Jul; 70(1):40-6. PubMed ID: 10446494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Prog Clin Biol Res; 1990; 337():141-9. PubMed ID: 2191308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.